Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)
Charles A. Herzog, Eberhard Ritz(Heidelberg University), Patrick H. Pun(Duke University), Rod Passman(Northwestern University), Richard Asinger(University of Minnesota), Javier Dı́ez(Universidad de Navarra), Peter A. McCullough(Providence Hospital), Stephanie DeLoach(Jefferson College), Robert G. Hart(Population Health Research Institute), Bertram L. Kasiske(Hennepin County Medical Center), David M. Charytan(Royal North Shore Hospital), Kai‐Uwe Eckardt(Friedrich-Alexander-Universität Erlangen-Nürnberg), Alan K. Berger(University of Minnesota System)
Cited by 925
Related Papers
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
|Kidney International|2005|3.9k
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report
|Kidney International|2010|2.3k
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
|New England Journal of Medicine|2006|2.1k
Part 8: Adult Advanced Cardiovascular Life Support
|Circulation|2010|1.6k